Hua MedicineHUMDF 46 Days Inventory is 198.26 as of Dec. 2025, which is 7% below its 10-year median of 213.13. GuruFocus rates HUMDF with a GF Score™ of 46/100 and a GF Value™ of $1.46 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 916 Drug Manufacturers companies, Hua Medicine ranks worse than 67.25% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). Hua Medicine's Average Total Inventories for the
six
months ended in Dec. 2025 was $17.42 Mil. Hua Medicine's Cost of Goods Sold for the
six
months ended in Dec. 2025 was $16.04 Mil.
Hence, Hua Medicine's Days Inventory for the
six
months ended in Dec. 2025 was 198.26.
The historical rank and industry rank for Hua Medicine's Days Inventory or its related term are showing as below:
HUMDF'
s Days Inventory Range Over the Past 10 Years
Min: 70.55 Med: 213.13 Max: 239.86
Current: 212.21
During the past 10 years, Hua Medicine's highest Days Inventory was 239.86. The lowest was 70.55. And the median was 213.13.
HUMDF's Days Inventory is ranked worse than 67.25% of 916
companies
in the Drug Manufacturers industry
Industry Median: 164.43
vs HUMDF: 212.21
Hua Medicine's Days Inventory
declined
from Dec. 2024 (239.50) to Dec. 2025 (198.26).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Hua Medicine's Inventory Turnover for the
six
months ended in Dec. 2025 was 0.92.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Hua Medicine's Inventory-to-Revenue for the
six
months ended in Dec. 2025 was 0.45.
Hua Medicine (OTCPK:HUMDF) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Hua Medicine's Inventory Turnover for the
six
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Hua Medicine's Inventory to Revenue for the
six
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Hua Medicine Days Inventory Related Terms
Hua Medicine Days Inventory Historical Data
* Premium members only.
The historical data trend for Hua Medicine's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Hua Medicine's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hua Medicine Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Hua Medicine's Days Inventory distribution charts can be found below:
* The bar in red indicates where Hua Medicine's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hua Medicine (HUMDF) has a Days Inventory of 198.26 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Hua Medicine and its competitors. This is near median its historical median of 213.13. Over the past decade, Hua Medicine's Days Inventory has ranged from 70.55 to 239.86. According to the industry distribution chart, Hua Medicine ranks #616 out of 916 companies in the Drug Manufacturers industry, placing it in the top 67.2%.
Is Hua Medicine's Days Inventory too high?
Hua Medicine's current Days Inventory of 198.26 is near median its 10-year median of 213.13. Over the past 10 years, this metric has ranged from a low of 70.55 to a high of 239.86. The Drug Manufacturers industry median Days Inventory is 164.43. Hua Medicine's value of 198.26 is 20.6% above this industry median. Based on the distribution chart, Hua Medicine ranks #616 out of 916 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Hua Medicine has a GF Score™ of 46/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Hua Medicine's Days Inventory compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Hua Medicine ranks #616 out of 916 companies for Days Inventory. This places Hua Medicine in the lower half of its industry. The industry median Days Inventory is 164.43. Hua Medicine's value of 198.26 is 20.6% above this benchmark. Historically, Hua Medicine's own Days Inventory has ranged from 70.55 to 239.86 over the past decade. While the company's 10-year median is 213.13 vs. the industry median of 164.43, Hua Medicine has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.43, based on 916 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hua Medicine's current Days Inventory of 198.26 is 20.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Hua Medicine and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hua Medicine's current Days Inventory is 198.26, which is near median its own 10-year median of 213.13. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hua Medicine stock overvalued right now?
Based on GuruFocus' analysis, Hua Medicine (HUMDF) is currently considered Possible Value Trap. The stock's GF Value™ is $1.46, compared to a current price of $0.34 — trading 76.7% below its estimated fair value. The current Days Inventory is 198.26, which is near median its 10-year median of 213.13 and 20.6% above the Drug Manufacturers industry median of 164.43. Hua Medicine's overall GF Score™ is 46/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Hua Medicine (HUMDF), the current Days Inventory is 198.26 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hua Medicine (HUMDF) Overvalued in 2026?
Based on GuruFocus' analysis, Hua Medicine stock appears to be undervalued.
The current stock price of $0.34 is trading 76.7% below its estimated GF Value™ of $1.46.
GuruFocus considers Hua Medicine to be Possible Value Trap.
Key valuation signals for HUMDF:
Days Inventory: 198.26 (near median its 10-year median of 213.13)
GF Value™: $1.46 vs. price of $0.34 (76.7% below fair value)
Industry Position: 20.6% above the Drug Manufacturers median (#616 of 916)
No single metric tells the full story. See the HUMDF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hua Medicine is an investment holding company. It is engaged in the development and commercialization of a first-in-class oral drug, Dorzagliatin (HMS5552), for the treatment of Type 2 diabetes. Dorzagliatin is a first-in-class glucokinase activator, or GKA, designed to control the progressive degenerative nature of diabetes by restoring glucose homeostasis in Type 2 diabetes. The group majorly operates and generates the majority of its revenue from the PRC.
46GF Score
Get the complete analysis for HUMDF
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HUMDF has been successfully added to your 
